カテゴリー： QYResearch, 世界

世界の1型糖尿病薬市場

◆英語タイトル：Global Type 1 Diabetes Drugs Market Professional Survey Report 2019
◆商品コード：DATA909X16984
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月22日（※2024年版があります。お問い合わせください）
◆ページ数：101
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、1型糖尿病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、インスリン、その他に、用途別には、ドラッグストア、病院、その他にセグメント区分し、1型糖尿病薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・1型糖尿病薬の世界市場概要
・1型糖尿病薬の製造コスト構成分析
・1型糖尿病薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・1型糖尿病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・1型糖尿病薬のセグメント分析（種類別）
（インスリン、その他）
・1型糖尿病薬のセグメント分析（用途別）
（ドラッグストア、病院、その他）
・1型糖尿病薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Novo Nordisk、Sanofi、Eli Lily、Adocia、Astellas Pharma、AstraZeneca、BHV Pharma、Biodel、Boehringer Ingelheim、Diamyd Therapeutics AB、）
・1型糖尿病薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Type 1 Diabetes Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Type 1 Diabetes Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Type 1 Diabetes Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Type 1 Diabetes Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Type 1 Diabetes Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novo Nordisk
Sanofi
Eli Lily
Adocia
Astellas Pharma
AstraZeneca
BHV Pharma
Biodel
Boehringer Ingelheim
Diamyd Therapeutics AB

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Insulins
Others

Segment by Application
Drugstore
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Type 1 Diabetes Drugs
1.1 Definition of Type 1 Diabetes Drugs
1.2 Type 1 Diabetes Drugs Segment by Type
1.2.1 Global Type 1 Diabetes Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Insulins
1.2.3 Others
1.3 Type 1 Diabetes Drugs Segment by Applications
1.3.1 Global Type 1 Diabetes Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Global Type 1 Diabetes Drugs Overall Market
1.4.1 Global Type 1 Diabetes Drugs Revenue (2014-2025)
1.4.2 Global Type 1 Diabetes Drugs Production (2014-2025)
1.4.3 North America Type 1 Diabetes Drugs Status and Prospect (2014-2025)
1.4.4 Europe Type 1 Diabetes Drugs Status and Prospect (2014-2025)
1.4.5 China Type 1 Diabetes Drugs Status and Prospect (2014-2025)
1.4.6 Japan Type 1 Diabetes Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Type 1 Diabetes Drugs Status and Prospect (2014-2025)
1.4.8 India Type 1 Diabetes Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Type 1 Diabetes Drugs
2.3 Manufacturing Process Analysis of Type 1 Diabetes Drugs
2.4 Industry Chain Structure of Type 1 Diabetes Drugs

3 Development and Manufacturing Plants Analysis of Type 1 Diabetes Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Type 1 Diabetes Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Type 1 Diabetes Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Type 1 Diabetes Drugs Production and Capacity Analysis
4.2 Type 1 Diabetes Drugs Revenue Analysis
4.3 Type 1 Diabetes Drugs Price Analysis
4.4 Market Concentration Degree

5 Type 1 Diabetes Drugs Regional Market Analysis
5.1 Type 1 Diabetes Drugs Production by Regions
5.1.1 Global Type 1 Diabetes Drugs Production by Regions
5.1.2 Global Type 1 Diabetes Drugs Revenue by Regions
5.2 Type 1 Diabetes Drugs Consumption by Regions
5.3 North America Type 1 Diabetes Drugs Market Analysis
5.3.1 North America Type 1 Diabetes Drugs Production
5.3.2 North America Type 1 Diabetes Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Type 1 Diabetes Drugs Import and Export
5.4 Europe Type 1 Diabetes Drugs Market Analysis
5.4.1 Europe Type 1 Diabetes Drugs Production
5.4.2 Europe Type 1 Diabetes Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Type 1 Diabetes Drugs Import and Export
5.5 China Type 1 Diabetes Drugs Market Analysis
5.5.1 China Type 1 Diabetes Drugs Production
5.5.2 China Type 1 Diabetes Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Type 1 Diabetes Drugs Import and Export
5.6 Japan Type 1 Diabetes Drugs Market Analysis
5.6.1 Japan Type 1 Diabetes Drugs Production
5.6.2 Japan Type 1 Diabetes Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Type 1 Diabetes Drugs Import and Export
5.7 Southeast Asia Type 1 Diabetes Drugs Market Analysis
5.7.1 Southeast Asia Type 1 Diabetes Drugs Production
5.7.2 Southeast Asia Type 1 Diabetes Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Type 1 Diabetes Drugs Import and Export
5.8 India Type 1 Diabetes Drugs Market Analysis
5.8.1 India Type 1 Diabetes Drugs Production
5.8.2 India Type 1 Diabetes Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Type 1 Diabetes Drugs Import and Export

6 Type 1 Diabetes Drugs Segment Market Analysis (by Type)
6.1 Global Type 1 Diabetes Drugs Production by Type
6.2 Global Type 1 Diabetes Drugs Revenue by Type
6.3 Type 1 Diabetes Drugs Price by Type

7 Type 1 Diabetes Drugs Segment Market Analysis (by Application)
7.1 Global Type 1 Diabetes Drugs Consumption by Application
7.2 Global Type 1 Diabetes Drugs Consumption Market Share by Application (2014-2019)

8 Type 1 Diabetes Drugs Major Manufacturers Analysis
8.1 Novo Nordisk
8.1.1 Novo Nordisk Type 1 Diabetes Drugs Production Sites and Area Served
8.1.2 Novo Nordisk Product Introduction, Application and Specification
8.1.3 Novo Nordisk Type 1 Diabetes Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Sanofi
8.2.1 Sanofi Type 1 Diabetes Drugs Production Sites and Area Served
8.2.2 Sanofi Product Introduction, Application and Specification
8.2.3 Sanofi Type 1 Diabetes Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Eli Lily
8.3.1 Eli Lily Type 1 Diabetes Drugs Production Sites and Area Served
8.3.2 Eli Lily Product Introduction, Application and Specification
8.3.3 Eli Lily Type 1 Diabetes Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Adocia
8.4.1 Adocia Type 1 Diabetes Drugs Production Sites and Area Served
8.4.2 Adocia Product Introduction, Application and Specification
8.4.3 Adocia Type 1 Diabetes Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Astellas Pharma
8.5.1 Astellas Pharma Type 1 Diabetes Drugs Production Sites and Area Served
8.5.2 Astellas Pharma Product Introduction, Application and Specification
8.5.3 Astellas Pharma Type 1 Diabetes Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 AstraZeneca
8.6.1 AstraZeneca Type 1 Diabetes Drugs Production Sites and Area Served
8.6.2 AstraZeneca Product Introduction, Application and Specification
8.6.3 AstraZeneca Type 1 Diabetes Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 BHV Pharma
8.7.1 BHV Pharma Type 1 Diabetes Drugs Production Sites and Area Served
8.7.2 BHV Pharma Product Introduction, Application and Specification
8.7.3 BHV Pharma Type 1 Diabetes Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Biodel
8.8.1 Biodel Type 1 Diabetes Drugs Production Sites and Area Served
8.8.2 Biodel Product Introduction, Application and Specification
8.8.3 Biodel Type 1 Diabetes Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Boehringer Ingelheim
8.9.1 Boehringer Ingelheim Type 1 Diabetes Drugs Production Sites and Area Served
8.9.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.9.3 Boehringer Ingelheim Type 1 Diabetes Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Diamyd Therapeutics AB
8.10.1 Diamyd Therapeutics AB Type 1 Diabetes Drugs Production Sites and Area Served
8.10.2 Diamyd Therapeutics AB Product Introduction, Application and Specification
8.10.3 Diamyd Therapeutics AB Type 1 Diabetes Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Type 1 Diabetes Drugs Market
9.1 Global Type 1 Diabetes Drugs Market Trend Analysis
9.1.1 Global Type 1 Diabetes Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Type 1 Diabetes Drugs Regional Market Trend
9.2.1 North America Type 1 Diabetes Drugs Forecast 2019-2025
9.2.2 Europe Type 1 Diabetes Drugs Forecast 2019-2025
9.2.3 China Type 1 Diabetes Drugs Forecast 2019-2025
9.2.4 Japan Type 1 Diabetes Drugs Forecast 2019-2025
9.2.5 Southeast Asia Type 1 Diabetes Drugs Forecast 2019-2025
9.2.6 India Type 1 Diabetes Drugs Forecast 2019-2025
9.3 Type 1 Diabetes Drugs Market Trend (Product Type)
9.4 Type 1 Diabetes Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Type 1 Diabetes Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Type 1 Diabetes Drugs
Table Global Type 1 Diabetes Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Type 1 Diabetes Drugs Production Market Share by Types in 2018
Figure Insulins Product Picture
Figure Others Product Picture
Table Global Type 1 Diabetes Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Type 1 Diabetes Drugs Consumption Market Share by Applications in 2018
Figure Drugstore
Figure Hospital
Figure Others
Figure Global Type 1 Diabetes Drugs Revenue (Million USD) (2014-2025)
Figure Global Type 1 Diabetes Drugs Production (K Units) (2014-2025)
Figure North America Type 1 Diabetes Drugs Market Size (Million USD) (2014-2025)
Figure Europe Type 1 Diabetes Drugs Market Size (Million USD) (2014-2025)
Figure China Type 1 Diabetes Drugs Market Size (Million USD) (2014-2025)
Figure Japan Type 1 Diabetes Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Type 1 Diabetes Drugs Market Size (Million USD) (2014-2025)
Figure India Type 1 Diabetes Drugs Market Size (Million USD) (2014-2025)
Table Type 1 Diabetes Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Type 1 Diabetes Drugs in 2018
Figure Manufacturing Process Analysis of Type 1 Diabetes Drugs
Figure Industry Chain Structure of Type 1 Diabetes Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Type 1 Diabetes Drugs Manufacturing Plants Distribution
Table Type 1 Diabetes Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Type 1 Diabetes Drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table Type 1 Diabetes Drugs Production (K Units) of Major Manufacturers (2014-2019)
Table Type 1 Diabetes Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Type 1 Diabetes Drugs Production Share by Manufacturers in 2018
Table Type 1 Diabetes Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Type 1 Diabetes Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Type 1 Diabetes Drugs Revenue Share by Manufacturers in 2018
Table Type 1 Diabetes Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Type 1 Diabetes Drugs Production by Regions 2014-2019 (K Units)
Table Global Type 1 Diabetes Drugs Production Market Share by Regions 2014-2019
Figure Global Type 1 Diabetes Drugs Production Market Share by Regions in 2018
Table Global Type 1 Diabetes Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Type 1 Diabetes Drugs Revenue Market Share by Regions 2014-2019
Figure Global Type 1 Diabetes Drugs Revenue Market Share by Regions in 2018
Table Global Type 1 Diabetes Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Type 1 Diabetes Drugs Consumption Market Share by Regions 2014-2019
Figure North America Type 1 Diabetes Drugs Production Growth Rate 2014-2019 (K Units)
Figure North America Type 1 Diabetes Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Type 1 Diabetes Drugs Production, Consumption Import and Export (K Units)
Figure Europe Type 1 Diabetes Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Type 1 Diabetes Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Type 1 Diabetes Drugs Production, Consumption Import and Export (K Units)
Figure China Type 1 Diabetes Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Type 1 Diabetes Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Type 1 Diabetes Drugs Production, Consumption Import and Export (K Units)
Figure Japan Type 1 Diabetes Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Type 1 Diabetes Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Type 1 Diabetes Drugs Production, Consumption Import and Export (K Units)
Figure Southeast Asia Type 1 Diabetes Drugs Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Type 1 Diabetes Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Type 1 Diabetes Drugs Production, Consumption Import and Export (K Units)
Figure India Type 1 Diabetes Drugs Production Growth Rate 2014-2019 (K Units)
Figure India Type 1 Diabetes Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Type 1 Diabetes Drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption Type 1 Diabetes Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Type 1 Diabetes Drugs Market Share by Application (2014-2019)
Table Novo Nordisk Type 1 Diabetes Drugs Production Sites and Area Served
Table Novo Nordisk Type 1 Diabetes Drugs Product Introduction, Application and Specification
Table Novo Nordisk Type 1 Diabetes Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novo Nordisk Type 1 Diabetes Drugs Production Growth Rate (2014-2019)
Table Novo Nordisk Type 1 Diabetes Drugs Production Market Share (2014-2019)
Figure Novo Nordisk Type 1 Diabetes Drugs Revenue Market Share (2014-2019)
Table Novo Nordisk Type 1 Diabetes Drugs Main Business and Markets Served
Table Sanofi Type 1 Diabetes Drugs Production Sites and Area Served
Table Sanofi Type 1 Diabetes Drugs Product Introduction, Application and Specification
Table Sanofi Type 1 Diabetes Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Type 1 Diabetes Drugs Production Growth Rate (2014-2019)
Table Sanofi Type 1 Diabetes Drugs Production Market Share (2014-2019)
Figure Sanofi Type 1 Diabetes Drugs Revenue Market Share (2014-2019)
Table Sanofi Type 1 Diabetes Drugs Main Business and Markets Served
Table Eli Lily Type 1 Diabetes Drugs Production Sites and Area Served
Table Eli Lily Type 1 Diabetes Drugs Product Introduction, Application and Specification
Table Eli Lily Type 1 Diabetes Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lily Type 1 Diabetes Drugs Production Growth Rate (2014-2019)
Table Eli Lily Type 1 Diabetes Drugs Production Market Share (2014-2019)
Figure Eli Lily Type 1 Diabetes Drugs Revenue Market Share (2014-2019)
Table Eli Lily Type 1 Diabetes Drugs Main Business and Markets Served
Table Adocia Type 1 Diabetes Drugs Production Sites and Area Served
Table Adocia Type 1 Diabetes Drugs Product Introduction, Application and Specification
Table Adocia Type 1 Diabetes Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Adocia Type 1 Diabetes Drugs Production Growth Rate (2014-2019)
Table Adocia Type 1 Diabetes Drugs Production Market Share (2014-2019)
Figure Adocia Type 1 Diabetes Drugs Revenue Market Share (2014-2019)
Table Adocia Type 1 Diabetes Drugs Main Business and Markets Served
Table Astellas Pharma Type 1 Diabetes Drugs Production Sites and Area Served
Table Astellas Pharma Type 1 Diabetes Drugs Product Introduction, Application and Specification
Table Astellas Pharma Type 1 Diabetes Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharma Type 1 Diabetes Drugs Production Growth Rate (2014-2019)
Table Astellas Pharma Type 1 Diabetes Drugs Production Market Share (2014-2019)
Figure Astellas Pharma Type 1 Diabetes Drugs Revenue Market Share (2014-2019)
Table Astellas Pharma Type 1 Diabetes Drugs Main Business and Markets Served
Table AstraZeneca Type 1 Diabetes Drugs Production Sites and Area Served
Table AstraZeneca Type 1 Diabetes Drugs Product Introduction, Application and Specification
Table AstraZeneca Type 1 Diabetes Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Type 1 Diabetes Drugs Production Growth Rate (2014-2019)
Table AstraZeneca Type 1 Diabetes Drugs Production Market Share (2014-2019)
Figure AstraZeneca Type 1 Diabetes Drugs Revenue Market Share (2014-2019)
Table AstraZeneca Type 1 Diabetes Drugs Main Business and Markets Served
Table BHV Pharma Type 1 Diabetes Drugs Production Sites and Area Served
Table BHV Pharma Type 1 Diabetes Drugs Product Introduction, Application and Specification
Table BHV Pharma Type 1 Diabetes Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table BHV Pharma Type 1 Diabetes Drugs Production Growth Rate (2014-2019)
Table BHV Pharma Type 1 Diabetes Drugs Production Market Share (2014-2019)
Figure BHV Pharma Type 1 Diabetes Drugs Revenue Market Share (2014-2019)
Table BHV Pharma Type 1 Diabetes Drugs Main Business and Markets Served
Table Biodel Type 1 Diabetes Drugs Production Sites and Area Served
Table Biodel Type 1 Diabetes Drugs Product Introduction, Application and Specification
Table Biodel Type 1 Diabetes Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biodel Type 1 Diabetes Drugs Production Growth Rate (2014-2019)
Table Biodel Type 1 Diabetes Drugs Production Market Share (2014-2019)
Figure Biodel Type 1 Diabetes Drugs Revenue Market Share (2014-2019)
Table Biodel Type 1 Diabetes Drugs Main Business and Markets Served
Table Boehringer Ingelheim Type 1 Diabetes Drugs Production Sites and Area Served
Table Boehringer Ingelheim Type 1 Diabetes Drugs Product Introduction, Application and Specification
Table Boehringer Ingelheim Type 1 Diabetes Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Type 1 Diabetes Drugs Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Type 1 Diabetes Drugs Production Market Share (2014-2019)
Figure Boehringer Ingelheim Type 1 Diabetes Drugs Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Type 1 Diabetes Drugs Main Business and Markets Served
Table Diamyd Therapeutics AB Type 1 Diabetes Drugs Production Sites and Area Served
Table Diamyd Therapeutics AB Type 1 Diabetes Drugs Product Introduction, Application and Specification
Table Diamyd Therapeutics AB Type 1 Diabetes Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Diamyd Therapeutics AB Type 1 Diabetes Drugs Production Growth Rate (2014-2019)
Table Diamyd Therapeutics AB Type 1 Diabetes Drugs Production Market Share (2014-2019)
Figure Diamyd Therapeutics AB Type 1 Diabetes Drugs Revenue Market Share (2014-2019)
Table Diamyd Therapeutics AB Type 1 Diabetes Drugs Main Business and Markets Served
Figure Global Type 1 Diabetes Drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Type 1 Diabetes Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Type 1 Diabetes Drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Type 1 Diabetes Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Type 1 Diabetes Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Type 1 Diabetes Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Type 1 Diabetes Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Type 1 Diabetes Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Type 1 Diabetes Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Type 1 Diabetes Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Type 1 Diabetes Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Type 1 Diabetes Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Type 1 Diabetes Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Type 1 Diabetes Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Type 1 Diabetes Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Type 1 Diabetes Drugs by Type (2019-2025)
Table Global Consumption (K Units) of Type 1 Diabetes Drugs by Application (2019-2025)
Table Type 1 Diabetes Drugs Distributors List
Table Type 1 Diabetes Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Novo Nordisk、Sanofi、Eli Lily、Adocia、Astellas Pharma、AstraZeneca、BHV Pharma、Biodel、Boehringer Ingelheim、Diamyd Therapeutics AB、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の1型糖尿病薬市場(Global Type 1 Diabetes Drugs Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp